ANTI-TUMOUR IMMUNITY BY NORMAL ALLOGENEIC BLOOD-TRANSFUSION IN RAT
- 1 January 1977
- journal article
- research article
- Vol. 27 (3) , 549-554
Abstract
Growth of transplantable KMT-17 [fibrosarcoma] tumor cells in syngeneic WKA/Mk rats was inhibited by i.v. preimmunization with whole blood from normal rats of allogeneic strains. The inhibitory effect was also observed in rats immunized with allogeneic white blood cells alone. The strength of the inhibitory effect mainly depended on the strain of donor rat used; blood from Donryu and Kyoto strain rats produced the strongest inhibition, blood from Tokyo and Fischer strain rats produced moderate inhibition to the syngeneic tumor growth. Blood from ACI/N strain rats did not produce the inhibition. The mechanism of blood transfusion in inhibiting tumor growth is not clear. GVH [graft vs. host] reaction probably does not play an important role in the mechanism of the inhibition effect, because the effect was obtained by immunization with mitomycin C-treated allogeneic white blood cells and also by the immunization with whole blood from F1 hybrid rats. The inhibitory effect may be due to nonspecific active immunization. Significance of blood transfusion with special reference to clinical immunotherapy of cancer is discussed.This publication has 16 references indexed in Scilit:
- Inhibition of syngeneic tumor growth in rats immunized with allogeneic skin graftsInternational Journal of Cancer, 1976
- EFFECT OF COMBINATION TREATMENT WITH CYCLOPHOSPHAMIDE AND NONSPECIFIC PASSIVE-IMMUNIZATION ON A TRANSPLANTABLE TUMOR IN WKA RATS1976
- Tumour-associated transplantation antigens of chemically induced sarcomata cross reacting with allogeneic histocompatibility antigensNature, 1975
- Resistance of guinea pigs to leukemia following transfer of immunocompetent allogeneic lymphoid cells.1972
- Cross-immunity among Syngeneic Tumors of MiceThe Tohoku Journal of Experimental Medicine, 1972
- Immunotherapy of Malignant DiseaseArchives of Surgery, 1969
- IMMUNOLOGICALLY COMPETENT CELLS IN THE TREATMENT OF MALIGNANT DISEASEThe Lancet, 1968
- Transfusion of Lymphocyte Antibodies and Lymphocytes from Multitransfused DonorsClinical Pediatrics, 1968
- Clinical Immunologic Study of Malignant DiseaseAnnals of Surgery, 1966
- PRELIMINARY OBSERVATIONS ON TREATMENT OF ADVANCED CANCER BY INJECTION OF ALLOGENEIC SPLEEN CELLS.1963